Last 12 months
Inside the activity.
0 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 09, 2020 Filed Apr 13, 2020 22:24 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
SaleCommon Stock | 10,000 | $79.06 | $790,600.00 |
DisclosureSEC source: 0001567619-20-007886 · doc1.xml · nonDerivative · entry 2 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,213 F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 13, 2019. Read SEC document |
| April 09, 2020 Filed Apr 13, 2020 22:24 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 10,000 | $21.51 | $215,100.00 |
DisclosureSEC source: 0001567619-20-007886 · doc1.xml · nonDerivative · entry 1 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,213 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 13, 2019. Read SEC document |
| April 08, 2020 Filed Apr 9, 2020 23:58 UTC |
Ajer Jeffrey RobertEVP, Chief Commercial Officer
|
SaleCommon Stock | 2,407 | $79.98 | $192,511.86 |
DisclosureSEC source: 0001567619-20-007786 · doc1.xml · nonDerivative · entry 1 Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,064 F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 20, 2019. Read SEC document |
| April 07, 2020 Filed Apr 9, 2020 00:54 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative | 1,000 | $0.00 Strike: $26.49 | $0.00 |
DisclosureSEC source: 0001567619-20-007702 · doc1.xml · derivative · entry 3 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,513 Underlying: Common Stock · 1,000 shares Expires 2021-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant. Read SEC document |
| April 07, 2020 Filed Apr 9, 2020 00:54 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 1,000 | $26.49 | $26,490.00 |
DisclosureSEC source: 0001567619-20-007702 · doc1.xml · nonDerivative · entry 1 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,213 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 00:39 UTC |
Ajer Jeffrey RobertEVP, Chief Commercial Officer
|
SaleCommon Stock | 1,537 | $82.00 | $126,034.00 |
DisclosureSEC source: 0001567619-20-007469 · doc1.xml · nonDerivative · entry 1 Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,471 F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 20, 2019. Read SEC document |
| March 25, 2020 Filed Mar 27, 2020 00:34 UTC |
Ajer Jeffrey RobertEVP, Chief Commercial Officer
|
SaleCommon Stock | 1,618 | $78.47 | $126,964.46 |
DisclosureSEC source: 0001567619-20-007062 · doc1.xml · nonDerivative · entry 2 Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,008 F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 20, 2019. Read SEC document |
| March 24, 2020 Filed Mar 27, 2020 00:34 UTC |
Ajer Jeffrey RobertEVP, Chief Commercial Officer
|
SaleCommon Stock | 2,041 | $74.36 | $151,768.76 |
DisclosureSEC source: 0001567619-20-007062 · doc1.xml · nonDerivative · entry 1 Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,626 F1 · date: Trade made pursuant to a 10b5-1 plan executed on December 20, 2019. Read SEC document |
| March 20, 2020 Filed Mar 25, 2020 01:07 UTC |
Mueller BrianSVP, Acting CFO
|
Tax withholdingCommon Stock | 414 | $73.05 | $30,242.70 |
DisclosureSEC source: 0001567619-20-006974 · doc1.xml · nonDerivative · entry 1 Mueller Brian · CIK 0001514980 · SVP, Acting CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,781 Read SEC document |
| March 20, 2020 Filed Mar 25, 2020 00:57 UTC |
BAFFI ROBERTPresident, Global Mfg/Tech Ops
|
Tax withholdingCommon Stock | 3,501 | $73.05 | $255,748.05 |
DisclosureSEC source: 0001567619-20-006972 · doc1.xml · nonDerivative · entry 1 BAFFI ROBERT · CIK 0001274826 · President, Global Mfg/Tech Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,138 Read SEC document |
| March 20, 2020 Filed Mar 25, 2020 00:53 UTC |
Davis George EricEVP, General Counsel
|
Tax withholdingCommon Stock | 3,309 | $73.05 | $241,722.45 |
DisclosureSEC source: 0001567619-20-006970 · doc1.xml · nonDerivative · entry 1 Davis George Eric · CIK 0001380710 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,842 Read SEC document |
| March 20, 2020 Filed Mar 25, 2020 00:48 UTC |
FUCHS HENRY JPresident, Worldwide R&D
|
Tax withholdingCommon Stock | 5,836 | $73.05 | $426,319.80 |
DisclosureSEC source: 0001567619-20-006968 · doc1.xml · nonDerivative · entry 1 FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,869 Read SEC document |
| March 20, 2020 Filed Mar 25, 2020 00:42 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 13,128 | $73.05 | $959,000.40 |
DisclosureSEC source: 0001567619-20-006966 · doc1.xml · nonDerivative · entry 1 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,213 Read SEC document |
| March 20, 2020 Filed Mar 25, 2020 00:37 UTC |
Ajer Jeffrey RobertEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 3,599 | $73.05 | $262,906.95 |
DisclosureSEC source: 0001567619-20-006964 · doc1.xml · nonDerivative · entry 1 Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,667 Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 00:46 UTC |
LAWLIS V BRYANDirector
|
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative | 3,750 | $0.00 Strike: $21.51 | $0.00 |
DisclosureSEC source: 0001567619-20-006723 · doc1.xml · derivative · entry 4 LAWLIS V BRYAN · CIK 0001247681 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,750 shares Expires 2020-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · date: Trade made pursuant to a 10b5-1 plan executed on May 1, 2019. F3 · balance_after: Reflects the number of options outstanding after the transactions from the specific stock option grant. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 00:46 UTC |
LAWLIS V BRYANDirector
|
SaleCommon Stock | 3,750 | $75.39 | $282,712.50 |
DisclosureSEC source: 0001567619-20-006723 · doc1.xml · nonDerivative · entry 3 LAWLIS V BRYAN · CIK 0001247681 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,980 F2 · date: Trade made pursuant to a 10b5-1 plan executed on May 1, 2019. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 00:46 UTC |
LAWLIS V BRYANDirector
|
Exercise / conversionCommon Stock | 3,750 | $21.51 | $80,662.50 |
DisclosureSEC source: 0001567619-20-006723 · doc1.xml · nonDerivative · entry 2 LAWLIS V BRYAN · CIK 0001247681 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,730 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · date: Trade made pursuant to a 10b5-1 plan executed on May 1, 2019. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 01:22 UTC |
Mueller BrianSVP, Acting CFO
|
GrantStock Option (Right to buy Common Stock) · Derivative | 9,600 | $0.00 Strike: $73.82 | $0.00 |
DisclosureSEC source: 0001567619-20-006637 · doc1.xml · derivative · entry 3 Mueller Brian · CIK 0001514980 · SVP, Acting CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,600 Underlying: Common Stock · 9,600 shares Expires 2030-03-15 F2 · date: Option grant vests 12/48th on March 16, 2021 and 1/48th on the 16th day of each month thereafter. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 01:22 UTC |
Mueller BrianSVP, Acting CFO
|
GrantCommon Stock | 6,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-006637 · doc1.xml · nonDerivative · entry 2 Mueller Brian · CIK 0001514980 · SVP, Acting CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,195 F1 · price: Restricted stock units granted on March 16, 2020. Price not applicable. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 01:19 UTC |
Davis George EricEVP, General Counsel
|
GrantStock Option (Right to buy Common Stock) · Derivative | 28,790 | $0.00 Strike: $73.82 | $0.00 |
DisclosureSEC source: 0001567619-20-006634 · doc1.xml · derivative · entry 3 Davis George Eric · CIK 0001380710 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,790 Underlying: Common Stock · 28,790 shares Expires 2030-03-15 F2 · date: Option grant vests 12/48th on March 16, 2021 and 1/48th on the 16th day of each month thereafter. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 01:19 UTC |
Davis George EricEVP, General Counsel
|
GrantCommon Stock | 10,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-006634 · doc1.xml · nonDerivative · entry 2 Davis George Eric · CIK 0001380710 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,151 F1 · price: Restricted stock units granted on March 16, 2020. Price not applicable. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 01:15 UTC |
FUCHS HENRY JPresident, Worldwide R&D
|
GrantStock Option (Right to buy Common Stock) · Derivative | 51,970 | $0.00 Strike: $73.82 | $0.00 |
DisclosureSEC source: 0001567619-20-006632 · doc1.xml · derivative · entry 3 FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,970 Underlying: Common Stock · 51,970 shares Expires 2030-03-15 F2 · date: Option grant vests 12/48th on March 16, 2021 and 1/48th on the 16th day of each month thereafter. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 01:15 UTC |
FUCHS HENRY JPresident, Worldwide R&D
|
GrantCommon Stock | 18,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-006632 · doc1.xml · nonDerivative · entry 2 FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,705 F1 · price: Restricted stock units granted on March 16, 2020. Price not applicable. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 01:08 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
GrantStock Option (Right to buy Common Stock · Derivative | 127,920 | $0.00 Strike: $73.82 | $0.00 |
DisclosureSEC source: 0001567619-20-006628 · doc1.xml · derivative · entry 4 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,920 Underlying: Common Stock · 127,920 shares Expires 2030-03-15 F2 · date: Option grant vests 12/48th on March 16, 2021 and 1/48th on the 16th day of each month thereafter. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 01:08 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
GrantCommon Stock | 44,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-006628 · doc1.xml · nonDerivative · entry 2 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,341 F1 · price: Restricted stock units granted on March 16, 2020. Price not applicable. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 01:11 UTC |
BAFFI ROBERTPresident, Global Mfg/Tech Ops
|
GrantStock Option (Right to buy Common Stock) · Derivative | 30,390 | $0.00 Strike: $73.82 | $0.00 |
DisclosureSEC source: 0001567619-20-006630 · doc1.xml · derivative · entry 4 BAFFI ROBERT · CIK 0001274826 · President, Global Mfg/Tech Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,390 Underlying: Common Stock · 30,390 shares Expires 2030-03-15 F2 · date: Option grant vests 12/48th on March 16, 2021 and 1/48th on the 16th day of each month thereafter. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 01:11 UTC |
BAFFI ROBERTPresident, Global Mfg/Tech Ops
|
GrantCommon Stock | 10,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-006630 · doc1.xml · nonDerivative · entry 2 BAFFI ROBERT · CIK 0001274826 · President, Global Mfg/Tech Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,639 F1 · price: Restricted stock units granted on March 16, 2020. Price not applicable. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 01:05 UTC |
Ajer Jeffrey RobertEVP, Chief Commercial Officer
|
GrantStock Option (Right to buy Common Stock) · Derivative | 29,590 | $0.00 Strike: $73.82 | $0.00 |
DisclosureSEC source: 0001567619-20-006626 · doc1.xml · derivative · entry 3 Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,590 Underlying: Common Stock · 29,590 shares Expires 2030-03-15 F2 · date: Option grant vests 12/48th on March 16, 2021 and 1/48th on the 16th day of each month thereafter. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 01:05 UTC |
Ajer Jeffrey RobertEVP, Chief Commercial Officer
|
GrantCommon Stock | 10,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-006626 · doc1.xml · nonDerivative · entry 2 Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,266 F1 · price: Restricted stock units granted on March 16, 2020. Price not applicable. Read SEC document |
| March 16, 2020 Filed Mar 19, 2020 00:46 UTC |
LAWLIS V BRYANDirector
|
SaleCommon Stock | 4,610 | $76.52 | $352,757.20 |
DisclosureSEC source: 0001567619-20-006723 · doc1.xml · nonDerivative · entry 1 LAWLIS V BRYAN · CIK 0001247681 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,980 F1 · date: Trade made pursuant to a 10b5-1 plan executed on January 16, 2020. Read SEC document |
| March 13, 2020 Filed Mar 18, 2020 01:22 UTC |
Mueller BrianSVP, Acting CFO
|
Tax withholdingCommon Stock | 1,303 | $84.50 | $110,103.50 |
DisclosureSEC source: 0001567619-20-006637 · doc1.xml · nonDerivative · entry 1 Mueller Brian · CIK 0001514980 · SVP, Acting CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,465 Read SEC document |
| March 13, 2020 Filed Mar 18, 2020 01:19 UTC |
Davis George EricEVP, General Counsel
|
Tax withholdingCommon Stock | 7,244 | $84.50 | $612,118.00 |
DisclosureSEC source: 0001567619-20-006634 · doc1.xml · nonDerivative · entry 1 Davis George Eric · CIK 0001380710 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,051 Read SEC document |
| March 13, 2020 Filed Mar 18, 2020 01:15 UTC |
FUCHS HENRY JPresident, Worldwide R&D
|
Tax withholdingCommon Stock | 10,496 | $84.50 | $886,912.00 |
DisclosureSEC source: 0001567619-20-006632 · doc1.xml · nonDerivative · entry 1 FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,485 Read SEC document |
| March 13, 2020 Filed Mar 18, 2020 01:08 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 30,952 | $84.50 | $2,615,444.00 |
DisclosureSEC source: 0001567619-20-006628 · doc1.xml · nonDerivative · entry 1 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,491 Read SEC document |
| March 13, 2020 Filed Mar 18, 2020 01:11 UTC |
BAFFI ROBERTPresident, Global Mfg/Tech Ops
|
Tax withholdingCommon Stock | 7,600 | $84.50 | $642,200.00 |
DisclosureSEC source: 0001567619-20-006630 · doc1.xml · nonDerivative · entry 1 BAFFI ROBERT · CIK 0001274826 · President, Global Mfg/Tech Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,979 Read SEC document |
| March 13, 2020 Filed Mar 18, 2020 01:05 UTC |
Ajer Jeffrey RobertEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 7,644 | $84.50 | $645,918.00 |
DisclosureSEC source: 0001567619-20-006626 · doc1.xml · nonDerivative · entry 1 Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,886 Read SEC document |
| March 09, 2020 Filed Mar 12, 2020 01:01 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative | 10,000 | $0.00 Strike: $21.51 | $0.00 |
DisclosureSEC source: 0001567619-20-006147 · doc1.xml · derivative · entry 5 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,000 Underlying: Common Stock · 10,000 shares Expires 2020-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 13, 2019. F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant. Read SEC document |
| March 09, 2020 Filed Mar 12, 2020 01:01 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
SaleCommon Stock | 10,000 | $89.52 | $895,200.00 |
DisclosureSEC source: 0001567619-20-006147 · doc1.xml · nonDerivative · entry 3 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,443 F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 13, 2019. F2 · date: The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 10 shares, with the reporting person's purchase of shares at a price of $75.3786 on November 11, 2019. The reporting person has paid to the Issuer the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs. Read SEC document |
| March 09, 2020 Filed Mar 12, 2020 01:01 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 10,000 | $21.51 | $215,100.00 |
DisclosureSEC source: 0001567619-20-006147 · doc1.xml · nonDerivative · entry 2 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,443 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 13, 2019. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 02:51 UTC |
FUCHS HENRY JPresident, Worldwide R&D
|
GrantCommon Stock | 13,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-005681 · doc1.xml · nonDerivative · entry 1 FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,981 F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis. F2 · shares: Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2019 as set forth in the Issuer's audited financial statements. F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 15, 2020, 2021 and 2022, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 02:48 UTC |
Davis George EricEVP, General Counsel
|
GrantCommon Stock | 9,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-005679 · doc1.xml · nonDerivative · entry 1 Davis George Eric · CIK 0001380710 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,295 F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis. F2 · shares: Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2019 as set forth in the Issuer's audited financial statements. F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 15, 2020, 2021 and 2022, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 02:44 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
GrantCommon Stock | 35,580 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-005677 · doc1.xml · nonDerivative · entry 1 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,413 F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis. F2 · shares: Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2019 as set forth in the Issuer's audited financial statements. F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 15, 2020, 2021 and 2022, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events. F4 · balance_after: Total has been adjusted to reflect transactions reported on Form 5 filed on February 13, 2020. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 02:41 UTC |
BAFFI ROBERTPresident, Global Mfg/Tech Ops
|
GrantCommon Stock | 9,852 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-005675 · doc1.xml · nonDerivative · entry 1 BAFFI ROBERT · CIK 0001274826 · President, Global Mfg/Tech Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,579 F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis. F2 · shares: Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2019 as set forth in the Issuer's audited financial statements. F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 15, 2020, 2021 and 2022, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 02:38 UTC |
Ajer Jeffrey RobertEVP, Chief Commercial Officer
|
GrantCommon Stock | 9,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-005673 · doc1.xml · nonDerivative · entry 1 Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,530 F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis. F2 · shares: Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2019 as set forth in the Issuer's audited financial statements. F3 · shares: Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 15, 2020, 2021 and 2022, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events. F4 · balance_after: On June 7, 2019, the reporting person filed a Form 4 which inadvertently over reported the total amount of securities beneficially owned by the reporting person by 50 shares. This Form 4 corrects such error by decreasing the total amount of securities beneficially owned by the reporting person by such 50 shares. Read SEC document |
| March 03, 2020 Filed Mar 12, 2020 01:01 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
OtherCommon Stock | 30 | $94.39 | $2,831.70 |
DisclosureSEC source: 0001567619-20-006147 · doc1.xml · nonDerivative · entry 1 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,443 Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 01:19 UTC |
Mueller BrianSVP, Acting CFO
|
GrantCommon Stock | 5,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-002150 · doc1.xml · nonDerivative · entry 2 Mueller Brian · CIK 0001514980 · SVP, Acting CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,768 F2 · price: Restricted stock units granted on February 3, 2020. Price not applicable. Read SEC document |
| February 03, 2020 Filed Feb 6, 2020 01:38 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative | 10,000 | $0.00 Strike: $21.51 | $0.00 |
DisclosureSEC source: 0001567619-20-002261 · doc1.xml · derivative · entry 4 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,000 Underlying: Common Stock · 10,000 shares Expires 2020-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 13, 2019. F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant. Read SEC document |
| February 03, 2020 Filed Feb 6, 2020 01:38 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
SaleCommon Stock | 10,000 | $83.50 | $835,000.00 |
DisclosureSEC source: 0001567619-20-002261 · doc1.xml · nonDerivative · entry 2 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 328,530 F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 13, 2019. Read SEC document |
| February 03, 2020 Filed Feb 6, 2020 01:38 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 10,000 | $21.51 | $215,100.00 |
DisclosureSEC source: 0001567619-20-002261 · doc1.xml · nonDerivative · entry 1 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 13, 2019. Read SEC document |
| January 30, 2020 Filed Feb 4, 2020 00:30 UTC |
BIENAIME JEAN JACQUESDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to buy Common Stock) · Derivative | 1,000 | $0.00 Strike: $21.51 | $0.00 |
DisclosureSEC source: 0001567619-20-001970 · doc1.xml · derivative · entry 3 BIENAIME JEAN JACQUES · CIK 0001221590 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,000 Underlying: Common Stock · 1,000 shares Expires 2020-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.